Tracy Beth Høeg to replace Richard Pazdur in FDA role

4 December 2025

The US Food and Drug Administration (FDA) has announced that Tracy Beth Høeg has been appointed acting director of the Center for Drug Evaluation and Research (CDER).

She takes over from Richard Pazdur, who became the latest to leave the role this week when he announced his retirement, apparently due to reservations about FDA’s Commissioner Marty Makary’s National Priority Voucher scheme and wider frustrations with Dr Makary and Vinay Prasad, head of the FDA's biologics division.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK







Company Spotlight



More Features in Pharmaceutical